| Lovastatin | IC50 | 37.0 [1] |
| Simvastatin | IC50 | 39.81 [1] |
| Simvastatin | Ki | 2.6 [1], 68000.0 [2] |
| Rosuvastatin | IC50 | 3.1 [1], 4.0 [2], 5.0 [3], 5.4 [4] |
| Rosuvastatin | Ki | 0.9 [1], 71000.0 [2] |
| Atorvastatin | IC50 | 6.0 [1], 11.6 [2], 12.9 [3] |
| Unii-B99nwa524X | IC50 | 1340.0 [1], 1600.0 [2], 3000.0 [3] |
| Pravastatin | IC50 | 30.0 [1], 400.0 [2] |
| Pravastatin sodium | IC50 | 30.0 [1], 1370.0 [2] |
| Vorinostat | IC50 | 10000.0 [1] |
| Mevastatin | IC50 | 23.0 [1], 28.4 [2] |
| alpha-Asarone | IC50 | 36.31 [1], 5860.0 [2] |
| Meglutol | IC50 | 4000.0 [1] |
| Meglutol | Ki | 23.5 [1] |
| 1-[(3S,10R,13R,14S,17R)-3-Hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-14-yl]ethanone | IC50 | 1000.0 [1], 20000.0 [2] |
| Methyl 2-(5-hydroxy-2-methoxy-4-propylphenoxy)acetate | IC50 | 39.81 [1], 6110.0 [2] |
| Dfgyvae | IC50 | 160.0 [1] |
| Dfgyvae | Ki | 51.0 [1] |
| 4,5-Dimethoxy-2-propylphenol | IC50 | 22.91 [1], 4790.0 [2] |
| Methyl 2-(4-butanoyl-5-hydroxy-2-methoxyphenoxy)acetate | IC50 | 44.67 [1], 6430.0 [2] |
| (3S,10R,13R,14S,17R)-14-(1-Hydroxyethyl)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | IC50 | 3000.0 [1], 20000.0 [2] |
| 2-[[2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[(2-Aminoacetyl)amino]-3-(4-fluorophenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]acetic acid | IC50 | 4820.0 [1] |
| 2-[[2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[(2-Aminoacetyl)amino]-3-(4-fluorophenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]acetic acid | Ki | 260.0 [1] |
| 1-(2-Hydroxy-4,5-dimethoxyphenyl)propan-1-one | IC50 | 24.55 [1], 4940.0 [2] |
| [(1S,3R,7S,8S,8Ar)-8-[2-[(2R,4R)-4-[tert-butyl(dimethyl)silyl]oxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] N-[7-(hydroxyamino)-7-oxoheptyl]carbamate | IC50 | 54.1 [1] |
| [(1S,3R,7S,8S,8Ar)-8-[(3R,5R)-3,5-dihydroxy-7-(hydroxyamino)-7-oxoheptyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 11.4 [1], 13.1 [2] |
| 1-[(3R,5R)-3,5-Dihydroxy-7-(hydroxyamino)-7-oxoheptyl]-5-(4-fluorophenyl)-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide | IC50 | 9.2 [1], 12.3 [2] |
| (E,3R,5S)-7-[4-(4-Fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-N,3,5-trihydroxyhept-6-enamide | IC50 | 43.7 [1] |
| [(1S,3R,7S,8S,8Ar)-8-[2-[(2R,4R)-4-[tert-butyl(dimethyl)silyl]oxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] N-[4-[1-[7-(hydroxyamino)-7-oxoheptyl]triazol-4-yl]phenyl]carbamate | IC50 | 36.5 [1] |
| [(1S,3R,7S,8S,8Ar)-8-[2-[(2R,4R)-4-[tert-butyl(dimethyl)silyl]oxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] N-[[4-[1-[7-(hydroxyamino)-7-oxoheptyl]triazol-4-yl]phenyl]methyl]carbamate | IC50 | 53.8 [1] |
| Calcium | IC50 | 8900.0 [1] |
| Epilovastatin | IC50 | 2.2 [1] |
| (6E)-7-[3-(4-Fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 28.0 [1] |
| 25-Hydroxycholesterol | IC50 | 300.0 [1] |
| Cerivastatin | IC50 | 10.0 [1] |
| 9-Octadecynoic acid | IC50 | 5000.0 [1] |
| Glenvastatin | IC50 | 5.0 [1] |
| 7-Oxo-ganoderic acid Z | IC50 | 22300.0 [1] |
| Ganoderic acid TR | IC50 | 21700.0 [1] |
| [(1S,3R,7S,8S)-8-[2-[(2R,4R)-4-Hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 12.1 [1] |
| (E,3R,5R)-7-[4,5-Bis(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 5.7 [1] |
| (2S)-3-[2-[(1S,2R,4Ar,8aR)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-2-hydroxy-2H-furan-5-one | IC50 | 30200.0 [1] |
| (4S)-4-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S,3S)-2-Amino-3-methylpentanoyl]amino]propanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid | IC50 | 201120.0 [1] |
| (3S)-3-[[(2S)-1-[(2S)-2-[(2-Aminoacetyl)amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-[[2-(carboxymethylamino)-2-oxoethyl]amino]-4-oxobutanoic acid | IC50 | 22310.0 [1] |
| 3,5-Dihydroxy-7-(4,5-bis(4-fluorophenyl)-2-(1-methylethyl)-1H-imidazol-1-yl)-6-heptenoic acid | IC50 | 6.15 [1] |
| [(1S,3R,7S,8S)-8-[2-[(2R,4R)-4-Hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate | IC50 | 18.0 [1] |
| 7-[4,5-Bis-(4-fluoro-phenyl)-2-isopropyl-imidazol-1-yl]-3,5-dihydroxy-hept-6-enoic acid | IC50 | 9.0 [1] |
| [(1S,3R,4Ar,7S,8S,8aS)-3-hydroxy-8-[2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2S)-2-methylbutanoate | IC50 | 1400.0 [1] |
| Lovastatin sodium salt | IC50 | 29.0 [1] |
| Tenivastatin sodium | IC50 | 12.0 [1] |
| Sodium;(E,3R,5S)-7-[5-(4-fluorophenyl)-3-propan-2-yl-1-pyridin-2-ylpyrazol-4-yl]-3,5-dihydroxyhept-6-enoate | IC50 | 8.0 [1] |
| Sodium;(E,3R,5S)-7-[5-(4-fluorophenyl)-3-propan-2-yl-1-pyrazin-2-ylpyrazol-4-yl]-3,5-dihydroxyhept-6-enoate | IC50 | 66.0 [1] |
| Sodium;(E,3R,5S)-7-[5-(4-fluorophenyl)-1-phenyl-3-propan-2-ylpyrazol-4-yl]-3,5-dihydroxyhept-6-enoate | IC50 | 7.0 [1] |
| Sodium;(3R,5R)-7-[3-(4-fluorophenyl)-4-phenyl-5-(phenylcarbamoyl)-1-propan-2-ylpyrrol-2-yl]-3,5-dihydroxyheptanoate | IC50 | 1.8 [1] |
| Gfpdgg | IC50 | 1520.0 [1] |
| Gfpegg | IC50 | 1780.0 [1] |
| L-Isoleucyl-L-alanyl-L-valyl-L-glutamic acid | IC50 | 75230.0 [1] |
| L-Tyrosyl-L-alanyl-L-valyl-L-glutamic acid | IC50 | 44810.0 [1] |
| L-Isoleucyl-L-valyl-L-alanyl-L-glutamic acid | IC50 | 52670.0 [1] |
| L-Tyrosyl-L-valyl-L-alanyl-L-glutamic acid | IC50 | 41210.0 [1] |
| Glptgg | IC50 | 19430.0 [1] |
| Gfptgg | IC50 | 16940.0 [1] |
| (4R)-6-[[2-(4-Fluorophenyl)-4,6-di(propan-2-yl)phenoxy]methyl]-4-hydroxyoxan-2-one | IC50 | 1.8 [1] |
| (4R)-6-[2-[4-(4-Fluorophenyl)-6-phenyl-2-propan-2-ylpyridin-3-yl]ethyl]-4-hydroxyoxan-2-one | IC50 | 370.0 [1] |
| (E,3R,5S)-7-[4-(4-Fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 0.01 [1] |
| (E,3R,5S)-7-[2,3-Bis(4-fluorophenyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 6.98 [1] |
| L-Leucyl-L-prolyl-L-tyrosyl-L-proline | IC50 | 484720.0 [1] |
| (4S)-4-[[(2S)-1-[(2S)-2-[(2-Aminoacetyl)amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-[[2-(carboxymethylamino)-2-oxoethyl]amino]-5-oxopentanoic acid | IC50 | 27280.0 [1] |
| F(4-Fluoro)VAE | IC50 | 3840.0 [1] |
| FPYVAE peptide [PMID: 20494585] | IC50 | 1470.0 [1] |
| (2S)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S,3S)-2-Amino-3-methylpentanoyl]amino]propanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoic acid | IC50 | 152190.0 [1] |
| CID 73348335 | IC50 | 4.8 [1] |
| 4-{(E)-2-[3-(5-Hydroxy-5-methyl-hexyl)-phenyl]-vinyl}-4-methyl-cyclohexanol | IC50 | 10000.0 [1] |
| (3R,5R)-7-[3,4-Bis(4-fluorophenyl)-5-(phenylcarbamoyl)-1-propan-2-ylpyrrol-2-yl]-3,5-dihydroxyheptanoic acid | IC50 | 1.8 [1] |
| [(1R,2S,3S,7S,8S)-2-Hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 13.3 [1] |
| [(1R,2S,3S,7S,8S)-8-[2-[(2R,4R)-4-Hydroxy-6-oxooxan-2-yl]ethyl]-2-[(R)-hydroxy(phenyl)methyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 19.7 [1] |
| [(1R,2S,3S,7S,8S)-2-[(1S)-1-Hydroxyethyl]-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 7.6 [1] |
| [(1R,2S,3S,7S,8S)-2-(Hydroxymethyl)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | IC50 | 10.8 [1] |
| [(1S,3R,4S,6S,7R,8S,8Ar)-4,6-dihydroxy-3,7-dimethyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl] (2S)-2-methylbutanoate | IC50 | 387000.0 [1] |
| (4R,6S)-6-[(E)-2-[4-(4-Fluorophenyl)-2,6-dimethylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 2000.0 [1] |
| (4R,6S)-6-[(Z)-2-[4-(4-Fluorophenyl)-2-methyl-6-phenylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 5000.0 [1] |
| (4R,6S)-6-[(E)-2-[4-(4-Fluorophenyl)-2-methyl-6-phenylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 90.0 [1] |
| (E)-6-{2-[4-(4-Fluoro-phenyl)-2,6-diisopropyl-pyridin-3-yl]-vinyl}-4-hydroxy-tetrahydro-pyran-2-one | IC50 | 20.0 [1] |
| (4R,6S)-6-[(E)-2-[6-Cyclohexyl-4-(4-fluorophenyl)-2-propan-2-ylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 9.5 [1] |
| (4R,6S)-6-[(E)-2-[2-Cyclohexyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 5000.0 [1] |
| (4R,6S)-6-[(E)-2-[4-(4-Fluorophenyl)-2-phenyl-6-propan-2-ylpyrimidin-5-yl]ethenyl]-4-hydroxyoxan-2-one | IC50 | 5.0 [1] |
| Sodium;(E,3R,5S)-7-[1-(1,3-benzothiazol-2-yl)-5-(4-fluorophenyl)-3-propan-2-ylpyrazol-4-yl]-3,5-dihydroxyhept-6-enoate | IC50 | 59.0 [1] |
| Sodium;(3R,5R)-7-[1-(4-fluorophenyl)-4-oxo-5-phenyl-3-propan-2-ylpyrrolo[2,3-c]quinolin-2-yl]-3,5-dihydroxyheptanoate | IC50 | 16.7 [1] |
| Sodium;7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyheptanoate | IC50 | 0.01 [1] |
| Sodium;(3R,5R)-7-[3-(4-fluorophenyl)-5-[(4-methoxyphenyl)methylcarbamoyl]-4-phenyl-1-propan-2-ylpyrrol-2-yl]-3,5-dihydroxyheptanoate | IC50 | 0.8 [1] |
| Sodium;(3R,5R)-7-[5-(ethylcarbamoyl)-3-(4-fluorophenyl)-4-phenyl-1-propan-2-ylpyrrol-2-yl]-3,5-dihydroxyheptanoate | IC50 | 12.0 [1] |
| Sodium;(3R,5R)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4H-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate | IC50 | 0.3 [1] |
| (4R)-6-[[2-[Chloro(cyclohexyl)methyl]-4,6-dimethylphenoxy]methyl]-4-hydroxyoxan-2-one | IC50 | 6500.0 [1] |
| (E,3R,5S)-7-[5-(4-Fluoro-3,5-dimethylphenyl)-4-(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 7.52 [1] |
| (E,3R,5S)-7-[5-(4-Fluoro-2-methylphenyl)-4-(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 8.4 [1] |
| (E,3R,5S)-7-[4,5-Bis(4-fluorophenyl)-2-(trifluoromethyl)imidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 7.89 [1] |
| (E,3R,5S)-7-[5-(3,5-Dimethylphenyl)-4-(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 7.25 [1] |
| (E,3R,5S)-7-[5-(3,5-Dichlorophenyl)-4-(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 7.66 [1] |
| (E,3R,5S)-7-[5-(3-Chlorophenyl)-4-(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 8.1 [1] |
| (E,3R,5S)-7-[2,4-Bis(4-fluorophenyl)-5-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid | IC50 | 9.0 [1] |